Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Cited by papers we hold 5

• Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies · 2023
  No notice
• Macrophages in immunoregulation and therapeutics · 2023
  No notice
• Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives · 2022
  Corrected
• Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity · 2022
  No notice
• Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies · 2021
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.